Literature DB >> 22470629

Expansive Masses Arising From The Clivus: The Role Of FDG-PET/CT In The Metabolic Assessment Of Skeletal Lesions.

Angelina Cistaro1, Sabina Durando, Francesco Pazè, Andrea Limberti, Maurizio Cogoni, Carola Juenemann, Isabella Morra, Maria Consuelo Valentini.   

Abstract

A patient with neurological symptoms underwent CT scan that showed a sellar and suprasellar mass with bone erosions, involving especially the clivus and the right petrous apex. The first diagnostic hypothesis was chordoma in relation to the mass position. The MRI showed a solid well-enhancing mass; moreover another circumscribed lesion, with similar signal pattern, was found in the left mandibular condyle. the signal and the presence of another lesion did not agree with diagnosis of chordoma. FDG-PET/CT study showed multiple pathological uptakes suggesting a metastatic disease. A trans-sphenoidal excisional biopsy was performed and the histopathological analysis showed a population of cells consistent with a plasmacell tumor, confirmed by the presence of a monoclonal gammopathy on blood analysis. Our case suggests that FDG-PET/CT can modify the diagnostic and therapeutic procedures in myeloma, by evaluating the bone marrow involvement.

Entities:  

Keywords:  Chordoma; FDG-PET; clivus lesion; plasmacytoma

Year:  2009        PMID: 22470629      PMCID: PMC3303275          DOI: 10.3941/jrcr.v3i11.170

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  10 in total

1.  The value and limitations of total body scan in the diagnosis of multiple myeloma: a comparison with conventional skeletal radiography.

Authors:  P N Scutellari; R Spanedda; L M Feggi; P M Cervi
Journal:  Haematologica       Date:  1985 Mar-Apr       Impact factor: 9.941

2.  Initial results in the assessment of multiple myeloma using 18F-FDG PET.

Authors:  H Schirrmeister; M Bommer; A K Buck; S Müller; P Messer; D Bunjes; H Döhner; L Bergmann; S N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

Review 3.  Positron emission tomography and bone metastases.

Authors:  Ignac Fogelman; Gary Cook; Ora Israel; Hans Van der Wall
Journal:  Semin Nucl Med       Date:  2005-04       Impact factor: 4.446

4.  Value of FDG PET in the assessment of patients with multiple myeloma.

Authors:  Miriam A Bredella; Lynne Steinbach; Gary Caputo; George Segall; Randall Hawkins
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 5.  Comprehensive review of intracranial chordoma.

Authors:  Eren Erdem; Edgardo C Angtuaco; Rudy Van Hemert; Jong S Park; Ossama Al-Mefty
Journal:  Radiographics       Date:  2003 Jul-Aug       Impact factor: 5.333

6.  Comparison of bone scintigraphy and radiography in multiple myeloma.

Authors:  J M Woolfenden; M J Pitt; B G Durie; T E Moon
Journal:  Radiology       Date:  1980-03       Impact factor: 11.105

Review 7.  Multiple myeloma: clinical review and diagnostic imaging.

Authors:  Edgardo J C Angtuaco; Athanasios B T Fassas; Ronald Walker; Rajesh Sethi; Bart Barlogie
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

8.  Thoracic chordoma: review and role of FDG-PET.

Authors:  N Miyazawa; K Ishigame; S Kato; Y Satoh; T Shinohara
Journal:  J Neurosurg Sci       Date:  2008-10-23       Impact factor: 2.279

9.  [Prevention and management of complications of endoscopic surgery for nasal-skull base neoplasms].

Authors:  Wei-Hong Jiang; Zhi-Hai Xie; Jian-Yun Xiao; Hua Zhang; Su-Ping Zhao
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2008-02

10.  18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.

Authors:  Cristina Nanni; Domenico Rubello; Elena Zamagni; Paolo Castellucci; Valentina Ambrosini; Giancarlo Montini; Michele Cavo; Filippo Lodi; Cinzia Pettinato; Gaia Grassetto; Roberto Franchi; Milton D Gross; Stefano Fanti
Journal:  In Vivo       Date:  2008 Jul-Aug       Impact factor: 2.155

  10 in total
  1 in total

Review 1.  Sellar and clival plasmacytomas: case series of 5 patients with systematic review of 65 published cases.

Authors:  Jane Lee; Edwin Kulubya; Barry D Pressman; Adam Mamelak; Serguei Bannykh; Gabriel Zada; Odelia Cooper
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.